Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
oleh: Pradip De, Yuling Sun, Jennifer H. Carlson, Lori S. Friedman, Brian R. Leyland-Jones, Nandini Dey
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2014-04-01 |
Deskripsi
No description available for this item.